Agency Father Generic Information Collection Request. 60-Day Public Comment Request, 52160-52161 [2021-20276]
Download as PDF
<![CDATA[
52160
Federal Register / Vol. 86, No. 179 / Monday, September 20, 2021 / Notices
and relabeling them to represent
different experiments in three (3) figure
panels in one (1) paper, including:
—Figure 3 in J Biol Chem. 2014,
representing chromatin-bound gH2AX levels in WT MEF (Figure 3A),
Ogg1¥/¥ MEF (Figure 3C), and Ogg1+
(rescue) MEF (Figure 3D) cells
transfected with a control or
expression vector and in the absence
or presence of irradiation
Dr. Wang entered into a Voluntary
Exclusion Agreement (Agreement) and
voluntarily agreed to the following:
(1) Respondent agreed to exclude
herself voluntarily for a period of four
(4) years beginning on August 4, 2021,
from any contracting or subcontracting
with any agency of the United States
Government and from eligibility for or
involvement in nonprocurement
programs of the United States
Government referred to as ‘‘covered
transactions’’ pursuant to HHS’
Implementation (2 CFR part 376) of
OMB Guidelines to Agencies on
Governmentwide Debarment and
Suspension, 2 CFR part 180 (collectively
the ‘‘Debarment Regulations’’).
(2) Respondent agreed to exclude
herself voluntarily from serving in any
advisory capacity to PHS including, but
not limited to, service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant for
a period of four (4) years, beginning on
August 4, 2021.
(3) As a condition of the Agreement,
Respondent will request that the
following papers be corrected or
retracted in accordance with 42 CFR
93.407(a)(1) and § 93.411(b):
• Cell Death Dis. 2014 Jan;5(1):e1024
• Cancer Res. 2012 Sep 15;72(18):4707–
13
• Cancer Res. 2012 Mar 1;72(5):1221–8
• DNA Repair (Amst). 2010 Nov
10;9(11):1170–5
Respondent will copy ORI and the
Research Integrity Officer at EU on the
correspondence.
Dated: September 15, 2021.
Wanda K. Jones,
Acting Director, Office of Research Integrity,
Office of the Assistant Secretary for Health.
[FR Doc. 2021–20268 Filed 9–17–21; 8:45 am]
BILLING CODE 4150–31–P
VerDate Sep<11>2014
16:49 Sep 17, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–xxxx]
Agency Father Generic Information
Collection Request. 60-Day Public
Comment Request
Office of the Secretary, Health
and Human Services (HHS).
ACTION: 60-Day notice of public
information collections.
AGENCY:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before November 19,
2021.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990-New-60D,
and project title for reference, to
Sherrette Funn, the Reports Clearance
Officer, Sherrette.funn@hhs.gov, or call
202–795–7714.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Evaluation of
the National Hypertension Control
Initiative (NHCI).
Type of Collection: NEW Generic.
SUMMARY:
OMB No. 0990—OS/Office of Minority
Health (OMH)
Abstract: As part of the federal
response to COVID–19, the U.S.
Department of Health and Human
Services (HHS) has funded a new
initiative involving two cooperative
agreements with the American Heart
Association (AHA) to improve COVID–
19-related health outcomes by
addressing hypertension (high blood
pressure) among racial and ethnic
minority populations.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
The $32 million project from the HHS
Office of Minority Health (OMH) and
the Health Resources and Services
Administration (HRSA) Bureau of
Primary Health Care will support the
implementation of the National
Hypertension Control Initiative (NHCI),
a national initiative to improve blood
pressure control among the most at-risk
populations, including racial and ethnic
minorities.
The NHCI will support 350
participating HRSA-funded health
centers by providing patient and
provider education and training for
effective hypertension control as well as
integration of remote blood pressure
monitoring technology into the
treatment of hypertension for patients
served by participating health centers.
The project will also utilize the
American Heart Association’s targeted
media campaigns and existing
partnerships with community-based
organizations (CBOs) to help reach
Black, Latino, and other impacted
communities with (i) culturally and
linguistically appropriate messages, (ii)
access to blood pressure screenings, and
(iii) connection to health centers to
encourage proper treatment and
management of hypertension of
screened individuals. This initiative
serves to increase the number of adult
patients with controlled hypertension
and reduce the potential risk of COVIDrelated health outcomes.
AHA aims to conduct an evaluation to
assess the feasibility of the
implementation of each of the three
NHCI strategies. The findings of this
evaluation will inform the improvement
and tailoring of AHA’s communication
approaches about the importance of and
techniques for improving blood pressure
control, including the benefits of
accurately measuring, rapidly acting,
and having a patient-focused approach
to blood pressure control.
Methodology: The evaluation of the
NHCI project will use a mixed methods
design, integrating both quantitative and
qualitative data collection and analyses.
Three main goals of data collection will
be to: (1) Track and monitor systems
change implementation process
information from Community Health
Centers (CHCs) on a quarterly basis, (2)
assess the capacity of NHCI partners to
implement the NHCI project, their
needs, the strengths and weaknesses of
the systems change approach, and the
feasibility of the implementation of the
NHCI in their organizations and
communities, and (3) assess the reach
and success of NHCI project strategies
implemented by partners.
E:\FR\FM\20SEN1.SGM
20SEN1
52161
Federal Register / Vol. 86, No. 179 / Monday, September 20, 2021 / Notices
ANNUALIZED BURDEN HOUR TABLE
Respondents
(If necessary)
Number of
respondents
Number of
responses per
respondents
Average
burden per
response
Total burden
hours
Community and Social Service Occupations (CBO quarterly data entry into
MERD) ..........................................................................................................
Consumers (ETS health lesson learning questionnaires) ...............................
Health care professionals (quarterly data entry in MERD) .............................
Health care professionals (annual focus group) ..............................................
Community and Social Service Occupations (annual focus group) ................
53
63,600
350
16
16
4
1
4
1
1
30/60
10/60
1.5
1.5
1.5
106
10,600
2100
24
24
Total ..........................................................................................................
64,035
........................
........................
12,854
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–20276 Filed 9–17–21; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Human Complex Mental Function
Study Section.
Date: October 14–15, 2021
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joanna Szczepanik, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 1000D
Bethesda, MD 20892 (301) 827–2242
szczepaj@csr.nih.gov
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Mechanisms of Cancer
Therapeutics—1 Study Section.
Date: October 18–19, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:49 Sep 17, 2021
Jkt 253001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Dolores Arjona
Mayor, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institute of Health, 6701 Rockledge Drive,
Room 806D, Bethesda, MD 20892, (301) 827–
8578, dolores.arjonamayor@nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Cellular and Molecular
Technologies Study Section.
Date: October 20–21, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tatiana V. Cohen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–455–2364,
tatiana.cohen@nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Drug Discovery and Molecular
Pharmacology Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804 Bethesda, MD 20892, 301–594–
7945 smileyja@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Acute Neural Injury and Epilepsy
Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201,
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Clinical Research and Field Studies of
Infectious Diseases Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pauline Cupit, Ph.D.,
Scientific Review Office,r Center for
Scientific Review National Institute of
Health, 6701 Rockledge Drive, Bethesda, MD
20892 301–827–3275, cupitcunninghpm@
mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Interdisciplinary Clinical Care in Specialty
Care Settings Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Abu Saleh Mohammad
Abdullah, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 827–4043,
abuabdullah.abdullah@nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genomics
Computational Biology and Technology
Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge, Drive
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
Bethesda, MD 20892 301–827–7088,
methode.bacanamwo@nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Clinical Integrative Cardiovascular
and Hematological Sciences Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 6:00 p.m.
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 86, Number 179 (Monday, September 20, 2021)]
[Notices]
[Pages 52160-52161]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20276]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-xxxx]
Agency Father Generic Information Collection Request. 60-Day
Public Comment Request
AGENCY: Office of the Secretary, Health and Human Services (HHS).
ACTION: 60-Day notice of public information collections.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before November 19,
2021.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 795-7714.
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-New-60D, and
project title for reference, to Sherrette Funn, the Reports Clearance
Officer, [email protected], or call 202-795-7714.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Evaluation of the National Hypertension
Control Initiative (NHCI).
Type of Collection: NEW Generic.
OMB No. 0990--OS/Office of Minority Health (OMH)
Abstract: As part of the federal response to COVID-19, the U.S.
Department of Health and Human Services (HHS) has funded a new
initiative involving two cooperative agreements with the American Heart
Association (AHA) to improve COVID-19-related health outcomes by
addressing hypertension (high blood pressure) among racial and ethnic
minority populations.
The $32 million project from the HHS Office of Minority Health
(OMH) and the Health Resources and Services Administration (HRSA)
Bureau of Primary Health Care will support the implementation of the
National Hypertension Control Initiative (NHCI), a national initiative
to improve blood pressure control among the most at-risk populations,
including racial and ethnic minorities.
The NHCI will support 350 participating HRSA-funded health centers
by providing patient and provider education and training for effective
hypertension control as well as integration of remote blood pressure
monitoring technology into the treatment of hypertension for patients
served by participating health centers. The project will also utilize
the American Heart Association's targeted media campaigns and existing
partnerships with community-based organizations (CBOs) to help reach
Black, Latino, and other impacted communities with (i) culturally and
linguistically appropriate messages, (ii) access to blood pressure
screenings, and (iii) connection to health centers to encourage proper
treatment and management of hypertension of screened individuals. This
initiative serves to increase the number of adult patients with
controlled hypertension and reduce the potential risk of COVID-related
health outcomes.
AHA aims to conduct an evaluation to assess the feasibility of the
implementation of each of the three NHCI strategies. The findings of
this evaluation will inform the improvement and tailoring of AHA's
communication approaches about the importance of and techniques for
improving blood pressure control, including the benefits of accurately
measuring, rapidly acting, and having a patient-focused approach to
blood pressure control.
Methodology: The evaluation of the NHCI project will use a mixed
methods design, integrating both quantitative and qualitative data
collection and analyses. Three main goals of data collection will be
to: (1) Track and monitor systems change implementation process
information from Community Health Centers (CHCs) on a quarterly basis,
(2) assess the capacity of NHCI partners to implement the NHCI project,
their needs, the strengths and weaknesses of the systems change
approach, and the feasibility of the implementation of the NHCI in
their organizations and communities, and (3) assess the reach and
success of NHCI project strategies implemented by partners.
[[Page 52161]]
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Number of
Respondents (If necessary) Number of responses per Average burden Total burden
respondents respondents per response hours
----------------------------------------------------------------------------------------------------------------
Community and Social Service Occupations (CBO 53 4 30/60 106
quarterly data entry into MERD)................
Consumers (ETS health lesson learning 63,600 1 10/60 10,600
questionnaires)................................
Health care professionals (quarterly data entry 350 4 1.5 2100
in MERD).......................................
Health care professionals (annual focus group).. 16 1 1.5 24
Community and Social Service Occupations (annual 16 1 1.5 24
focus group)...................................
---------------------------------------------------------------
Total....................................... 64,035 .............. .............. 12,854
----------------------------------------------------------------------------------------------------------------
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2021-20276 Filed 9-17-21; 8:45 am]
BILLING CODE 4150-29-P
